Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-21

FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA supplemental approval granted to Torrent Pharmaceuticals Limited for pramipexole dihydrochloride, a generic product, enabling its market entry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole dihydrochloride (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DIHYDROCHLORIDE)